- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT07654959
Test Anxiety on Bowel Health and Constipation in Students
The Effect of Test Anxiety on Bowel Health and Constipation in University Students
This observational cross-sectional study aims to examine the relationship between test anxiety, bowel health, and constipation in university students. The study will include undergraduate students aged 18 years and older who are studying in the Physiotherapy and Rehabilitation Department at Lokman Hekim University and who are in their final examination period.
Participants will complete self-report questionnaires during a single face-to-face assessment session. Constipation status will be evaluated using the Rome IV criteria, stool form will be assessed using the Bristol Stool Scale, constipation severity will be assessed using the Constipation Severity Instrument, and test anxiety level will be assessed using the Test Anxiety Inventory. Sociodemographic characteristics and bowel-related symptoms will also be recorded.
The study does not include any intervention or treatment. The findings are expected to help better understand whether test anxiety during examination periods is associated with bowel health problems and constipation in university students.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
Constipation is a common gastrointestinal problem that may affect quality of life, daily activities, and psychosocial well-being. University students may be particularly vulnerable to bowel habit changes during examination periods because of increased academic stress and test-related anxiety.
This study is designed as an observational, cross-sectional, and analytical study. It will evaluate whether test anxiety is associated with bowel health indicators and constipation among university students during the final examination period. The study will be conducted at Lokman Hekim University with undergraduate students from the Department of Physiotherapy and Rehabilitation.
After providing informed consent, participants will complete self-report forms and questionnaires in a single face-to-face assessment session. The assessment will include questions about sociodemographic characteristics, bowel habits, bowel-related symptoms, constipation status, stool form, constipation severity, and test anxiety level. No intervention, treatment, randomization, or follow-up assessment will be performed.
The study is expected to provide information about the possible relationship between psychological stress related to examinations and bowel health in university students. The findings may contribute to a better understanding of stress-related bowel problems and may support future preventive approaches for young adults.
Tipo de estudo
Inscrição (Estimado)
Contactos e Locais
Contato de estudo
- Nome: Demet Öztürk, Phd
- Número de telefone: +905068394288
- E-mail: demett.ozturkk@gmail.com
Estude backup de contato
- Nome: Mustafa Sarı, Phd
- Número de telefone: +905068394288
- E-mail: mustafa.sari@lokmanhekim.edu.tr
Locais de estudo
-
-
Ankara
-
Ankara, Ankara, Turquia (Türkiye), 06510
- Recrutamento
- Lokman Hekim University, Ankara, Ankara
-
Contato:
- Demet Öztürk, Phd
- Número de telefone: 05068394288
- E-mail: demett.ozturkk@gmail.com
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Filho
- Adulto
- Adulto mais velho
Aceita Voluntários Saudáveis
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Being an undergraduate student in the Department of Physiotherapy and Rehabilitation at Lokman Hekim University
- Being in the final examination period during the data collection process
- Having sufficient reading and comprehension skills to complete the questionnaires independently
- Voluntarily agreeing to participate in the study after reading and signing the informed consent form
Exclusion Criteria:
- Having inflammatory bowel disease, such as Crohn's disease or ulcerative colitis, celiac disease, colorectal cancer, or a history of major gastrointestinal surgery
- Having diagnosed irritable bowel syndrome or another organic gastrointestinal disease
- Regular use of laxatives or medications that directly affect bowel movements, such as opioids
- Having neurological diseases that may affect bowel function, such as multiple sclerosis, Parkinson's disease, or spinal cord injury
- Having had an acute gastrointestinal infection within the last month
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
University Students
Undergraduate students aged 18 years and older who are studying in the Department of Physiotherapy and Rehabilitation at Lokman Hekim University and who are in their final examination period.
Participants will complete self-report questionnaires assessing test anxiety, bowel habits, stool form, constipation status, and constipation severity during a single face-to-face assessment session.
|
Os participantes preencheram formulários de avaliação e diários.
Nenhuma intervenção foi administrada.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Constipation Status Assessed by the Rome IV Criteria
Prazo: Baseline (Day 1)
|
Constipation status will be assessed using the Rome IV criteria.
This outcome will be reported as a binary classification: presence or absence of constipation.
Participants will be classified as having constipation or not having constipation according to constipation-related symptoms, including reduced stool frequency, straining, hard stools, sensation of incomplete evacuation, sensation of anorectal obstruction, and need for manual maneuvers.
The Rome IV criteria will not be reported as a scale score.
|
Baseline (Day 1)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Constipation Severity Assessed by the Constipation Severity Instrument
Prazo: Baseline (Day 1)
|
Constipation severity will be assessed using the Constipation Severity Instrument.
The scale includes 16 items and evaluates constipation-related symptoms across three subdomains: obstructive defecation, colonic inertia, and pain.
The total score ranges from 0 to 73, with higher scores indicating more severe constipation symptoms.
|
Baseline (Day 1)
|
|
Stool Form Assessed by the Bristol Stool Scale
Prazo: Baseline (Day 1)
|
Stool form will be assessed using the Bristol Stool Scale.
The Bristol Stool Scale is a 7-point stool form classification scale ranging from Type 1 to Type 7. Type 1 indicates separate hard lumps, and Type 7 indicates watery stool with no solid pieces.
Higher scores do not indicate a better or worse outcome; lower scores generally indicate harder stool forms, while higher scores indicate looser stool forms.
Participants will be asked to select the stool type that best represents their most common stool form during the last week.
|
Baseline (Day 1)
|
|
Test Anxiety Level Assessed by the Test Anxiety Inventory
Prazo: Baseline (Day 1)
|
Test anxiety level will be assessed using the Test Anxiety Inventory.
The scale consists of 20 self-report items evaluating cognitive, emotional, and physiological symptoms of anxiety experienced before and during examinations.
Total scores range from 20 to 80, with higher scores indicating higher test anxiety.
|
Baseline (Day 1)
|
|
Bowel Habits and Bowel-Related Symptoms
Prazo: Baseline (Day 1)
|
Bowel habits and bowel-related symptoms will be assessed using a researcher-developed evaluation form.
The form includes questions about stool frequency, postponement of defecation, perceived bowel health, preferred toilet type, and symptoms such as abdominal pain, bloating, gas, diarrhea, nausea, vomiting, indigestion, and constipation during the last week.
|
Baseline (Day 1)
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Estimado)
Conclusão do estudo (Estimado)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- 2026032
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .